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Abstract 
The chemical constituents of decoction (individual) and concoction (mixed) 
of ethanolic leaf extracts from Azadirachta indica (neem) and Ocimum 
sanctum (tulsi) were analyzed by gas chromatography-mass spectro-
photometery (GC-MS). Decoctions of A. indica and O. sanctum had 24 and 
33 constituents, respectively. Mixed together, 26 compounds were 
identified. Four major (high percentage) compounds were identified in A. 
indica: n-hexadecanoic acid (14.34%), phytol (19.96%), 9,12,15-octa-
decatrienoic acid, (Z,Z,Z)- (18.57%), and vitamin E (11.37%). Three 
major compounds were identified in O. sanctum: phenol,2-methoxy-3-(2-
propenyl) (15.32%), 9,12,15-octadecatrienoic acid,(Z,Z,Z)- (16.94%), 
and 9,12,15-octadecatrienoic acid, methyl ester,(Z,Z,Z)- (22.05%). Three 
major compounds were identified in the mixed extract: n-hexadecanoic 
acid (16.58%), phenol,2-methoxy-3-(2-propenyl) (20.62%), and 9,12,15-
octadecatrienoic acid,(Z,Z,Z) (25.98%). Four of the compounds in the 
mixed extract were new: eudesma-4(14),11-diene (0.18%), 6-
azabicyclo[3.2.1]octane (0.51%), cyclohexane,1-ethyl-1-methyl-2,4-
bis(1-methylenyl)-,[1S-(1α,2β,4β)]-β-Elemen (0.77%), and globulol 
(1.45%). The mixed extract had a high level of antimicrobial activity 
against fish pathogens as indicated by zone of inhibition, minimum 
inhibitory concentration, and minimum bactericidal concentration. 
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Introduction 
Aeromonas hydrophila, a heterotrophic gram-negative pathogenic bacterium 
prevalent in marine and freshwater ecosystems, causes motile Aeromonas 
septicemia (MAS) and associated economic losses in fisheries worldwide. It is 
responsible for a range of diseases in fish and amphibians including 
hemorrhagic septicemia (Karunasagar et al., 1995; Leung et al., 1995), where 
lesions lead to scale shedding, hemorrhages in the gills and anal area, ulcers, 
exophthalmia, and abdominal swelling. Other pathogens have been identified 
in aquatic systems, causing a wide range of fish diseases, including 
Staphylococcus aureus (Nemetz and Shotts, 1992), Staphylococcus 
epidermidis (Gunn et al., 1982), Pseudomonas aeruginosa (Govan and 
Deretic, 1996), and Vibrio harveyi (Govindachari, 1992)  
 As a result, alternative antimicrobial agents have been sourced from 
natural products. Traditional health remedies are popular with about 80% of 
the world’s population in Asia, Latin America, and Africa, with minimal 
reported side effects. Medicinal plants have been model sources of medicines 
as they are a reservoir of chemical agents with therapeutic properties 
(Bhuvaneswari and Balasundaram, 2006; Bai et al., 2009). Pharmaceutical 
companies have spent considerable resources in the development of new 
therapeutic products from plants. 
 Azadirachta indica is a tree from the mahogany family indigenous to India 
and southeast Asia. Commonly called the neem tree, it contains a vast 
amount of bioactive compounds that are chemically diverse and is an 
important alternative herbal therapy (Subapriya and Nagini, 2005). Neem 
extract suppresses several species of pathogenic bacteria such as 
Staphylococcus aureus, Salmonella typhosa, and Mycobacterium tuberculosis 
(Chaurasia and Jain, 1978; Rao et al., 1986) and arrests the growth of 
Salmonella paratyphi and Vibrio cholerae (Rao et al., 1986). 
  Ocimum sanctum (tulsi), of the Lamiaceae (mint) family, grows in India 
and Suriname. Its leaf extract has been used to treat a variety of conditions 
including catarrhal bronchitis, dysentery, and skin diseases. Its herbal extract 
produces hypoglycemic effects in rats. Aqueous and solvent extracts of tulsi 
stimulate humoral and cellular immunity in rats (Platel and Srinivasan, 2000) 
and aids in ulcer healing, which involves a combination of wound retraction 
and re-epithelialization, and promotes anti-ulcer activity (Godhwani et al., 
1988; Perini et al., 2003). 
 Given their antimicrobial abilities, the potentially active compounds of 
neem and tulsi should be identified. The rational exploitation of plant 
materials, both in traditional medicine and in the empirical development of 
new antibacterial drugs, provides a potentially productive avenue of research. 
In this study, we used GC-MS and antimicrobial activity against fish 
pathogens to identify principle and new compounds in individual and 
combined extracts of A. indica and O. sanctum. 
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Materials and Methods 
Preparation of extracts. Fresh leaves of A. indica (neem) and O. sanctum 
(tulsi) were collected between April and June 2007 at Tiruchirapalli, Tamil 
Nadu, India. The leaves were surface sterilized with 0.1% mercuric chloride 
(w/v) solution, washed thoroughly in running tap water for 10 min, and shade 
dried for 10 days until the weight was constant at room temperature (32-
35°C) for 5 days. Each sample was finely powdered in an electric blender. The 
ethanolic decoctions and concoction were obtained using the procedures of 
Iwalokun et al. (2001). Twenty grams, each, of A. indica and O. sanctum 
were extracted successively with 60 ml of ethanol using a Soxhlet apparatus 
for 48 h at 45°C for individual and combined (1:1) extracts. The ethanolic 
extracts were filtered thoroughly through Whatman filter paper (no. 1) and 
concentrated in a rotary vacuum evaporator at 50°C. The obtained residues 
were stored in a freezer at -80°C until GC-MS analysis and antimicrobial 
activity tests. 
 Gas chromatography-mass spectrometry analysis (GC-MS). One µl of 
decoction and concoction extracts were injected and analyzed by GC-MS. The 
chemical compositions of the ethanolic leaf extracts were determined by the 
Technological Development Center (PADETEC) of the Federal University of 
Ceara using GC-MS with a Hewlett-Packard 5971 GC/MS apparatus (Avondale, 
PA, USA) under the following conditions: a 0.25 mm × 30 m 
polydimethylsiloxane DB-1 fused silica capillary column with a film thickness 
of 0.10 µm; helium as the carrier gas (1 ml/min); injector temperature of 
250ºC; detector temperature of 200ºC. The column temperature ranged 35-
180ºC/min at 4ºC V/min, then 180-280ºC at 20ºC V/min. Mass spectra were 
obtained by electronic impact 70 eV. The compounds were identified by 
comparison of retention indices (RRI) with those reported in related literature 
and by comparison of their mass spectra with the Wiley library (Lin et al., 
1999) or published mass spectra (Massada, 1976). 
 Bacterial strains. To assay antibacterial activity, ethanolic extracts were 
dissolved in 5% DMSO to a final concentration of 100 mg/ml. In vitro 
antimicrobial activities of individual and combined extracts were evaluated 
against six fish pathogens obtained from the Microbial Type Culture Collection, 
Institute of Microbial Technology, Chandigarh, India: Aeromonas hydrophila 
(MTCC 646), Staphylococcus aureus (MTCC 87), Streptococcus epidermidis 
(MTCC 3382), Pseudomonas aeruginosa (MTCC 1034), Vibrio harveyi (MTCC 
7771), and Vibrio vulnificus (MTCC 1145). The tested organisms were grown 
on Mueller-Hinton agar (MHA, Hi-Media) and stored at -4°C; sub-cultures 
were grown and checked for purity every two weeks. 
 Susceptibility test. The inhibition zones of the extracts were determined 
according to guidelines of the National Committee for Clinical Laboratory 
Standards (Adams, 2001). The test bacterial strains were inoculated into MHA 
Hi-Media and incubated for 3-6 h at 35°C in a shaker until the culture 
turbidity changed to 0.5 on the McFarland unit. The final inoculum of each 
strain was adjusted to approximately 5 × 104 cfu/ml. Susceptibility tests 
followed a modified agar-well diffusion method (NCCLS, 1993). One ml of this 
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standard suspension, in each test bacterial strain, was spread evenly on MHA 
plates using an ‘L’ sterile glass rod spreader, after which the plates were 
allowed to dry at room temperature. Subsequently, 6-mm diameter wells in 
triplicate were bored in the agar and 100 μl from each extract (i.e., decoction 
or concoction) were reconstituted in 5% DMSO/distilled water to transfer into 
the wells. The plates were incubated at room temperature for 2 h to allow 
diffusion of the extract into the agar, then incubated at 37°C for 24 h. The 
zone of inhibition (diameter) was measured to the nearest millimeter. 
Tetracycline (25 μg/ml) was used as a positive control and 5% DMSO as a 
negative control. The tests were performed in duplicate for each 
microorganism. 
 Minimum inhibitory concentration (MIC). The MIC of the ethanolic extracts 
was determined by macro broth dilution assay (Adams, 2001). Two-fold serial 
dilution of the ethanolic decoctions and concoction (0.1-100 mg/ml), the 
negative control (5% DMSO), and the positive control (tetracycline; 0.125-
512 μg/ml) were prepared in tubes with MHA. The dilutions were seeded with 
test organisms at the standard concentration of 5 × 104 cfu/ml. The tubes 
were incubated at 37°C for 24 h and then examined for growth. The zone of 
inhibition of the lowest extract or control concentration was taken as the MIC. 
 Minimal bactericidal concentration (MBC). MBC was determined by 
aspirating 0.1 ml of the culture medium from tubes (in the macro broth MIC 
assay for ethanolic extracts) showing no apparent growth and subculturing it 
on fresh MHA at 37°C for 24 h. MBC was read as the least concentration 




Identification of compounds. The chemical constituents of the ethanolic 
decoction and concoction leaf extracts obtained from A. indica and O. sanctum 
are listed in order of their elution from the Elite-1 (100% dimethyl poly 
siloxane) 30 m x 0.25 mm ID x 1 l df capillary column. Using GC-MS, 24 
chemical constituents were identified from the ethanolic leaf extract of A. 
indica (Table 1). Of these, four compounds constituted over 10% of the 
extract and are considered major constituents. Thirty-three constituents were 
identified from the ethanolic leaf extract of O. sanctum; three are considered 
major constituents (Table 2). Twenty-six constituents were identified from the 
concoction, with three major constituents above 10% (Table 3). 
 Antimicrobial activity. The ethanolic leaf extracts of A. indica and A. 
indica+O.sanctum showed stronger antibacterial activity against A. hydrophila 
than the O. sanctum extract (Table 4). The positive control, tetracycline, 
showed strong inhibition against A. hydrophila while the negative control, 
DMSO, showed no inhibitory action. The least antimicrobial activity was found 
against V. vulnificus. Antimicrobial activity against the tested strains was 
ranked in the following order: A. hydrophila<S. aureus<V. harveyi<S. 
epidermidis<P. aeruginosa<V. vulnificus. The MIC of the combined extract 
was lower than that of either decoction or tetracycline against A. hydrophila 
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and moderate against S. aureus. This trend was similar in the MBC activity, 
which were within two-fold dilutions of the MIC. 
 
 Table 1. Chemical constituents from ethanolic Azardirachta indica leaf extract using 
GC-MS. 
 
 RT MF MW Peak 
(%) 
Compound 
**1 4.10 C3H8O3 92 2.57 Glycerin 
2 4.85 C6H10O2 114 0.90 2-Hexenoic acid,(E)- 
3 5.40 C9H13N 135 0.81 Benzeneethanamine,α-methyl- 
**4 6.14 C5H6N2O2 126 1.94 Thymine 
**5 7.60 C6H8O4 144 3.14 4H-Pyran-4-one,2,3-dihydro-,5-dihydroxy-6-methyl- 
6 8.02 C15H19NO7 325 0.41 Glucosamine,N-acetyl-N-benzoyl- 
7 9.01 C6H6O3 126 0.79 2-Furancarboxadehyde,5-(hydroxymethyl)- 
**8 12.53 C10H12O2 164 6.26 Eugenol 
9 13.86 C15H24 204 0.40 Naphthalene,1,2,3,4,4a,5,6,8a-octahydro-4a,8-
dimethyl-2-(1-methylethenyl)-,[2R-(2α,4aα,8aβ)]- 
10 14.73  C15H24 204  0.49 Caryophyllene 
11 14.83 C15H24 204 0.78 γ-Elemene 
12 9.01 C6H6O3  126  0.79  2-Furancarboxadehyde,5-(hydroxymethyl)- 
**13 17.45  C12H24O2  200  2.90  Dodecanoic acid 
14 17.96 C15H24 204 0.83 Azulene,1,2,3,3a,4,5,6,7-octahydro-1,4-dimethyl-7-
(1-methylenyl)-,[1R-(1α,3aβ,4α,7β)]- 
15 18.45  C15H24O  220  0.91  Caryophyllene oxide 
**16 18.97  C6H12O6  180  4.28  d-Mannose 
**17 21.22  C15H24O  220  1.56  Tricyclo[5.2.2.0(1,6)]undecan-3-ol,2-methylene-
6,8,8-trimethyl- 
**18 23.58  C20H40O  296  2.23  3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
19 24.43  C18H32O2  280  0.47  9,12-Octadecadienoic acid,(Z,Z)- 
*20 25.96  C16H32O2  256  14.34  n-Hexadecanoic acid 
*21 28.79 C20H40O 296 19.96 Phytol 
*22 29.27  C18H30O2  278  18.57  9,12,15-Octadecatrienoic acid,(Z,Z,Z)- 
**23 29.61  C18H36O2  284  3.76  Octadecanoic acid 
*24 37.15  C29H50O2  430  11.37  Vitamin E 
* Major constituent (≥10%), ** Minor constituent (1-10%) 
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 Table 2. Chemical constituents from ethanolic Ocimum sanctum leaf extract using 
GC-MS. 
 
 RT MF MW Peak 
(%) 
Compound 
**1 4.50  C6H14O5  166 1.74 Diglycerol 
2 5.40  C9H13N  135 0.07 Benzeneethanamine,α-methyl-  
3 6.27  C5H6N2 O2  126 0.23 Thymine  
4 6.65  C9H17N  69 0.55 1H-Pyrrole,2,5-dihydro- 
5 7.64  C6H8O4  144 0.45 4H-Pyran-4-one,2,3-dihydro-3,5-dihydroxy-6-
methyl-  
6 8.18  C15H19No7  325 0.11 Glucosamine,N-acetyl-N-benzoyl- 
**7 9.16  C6H6O3  126 1.23 2-Furancarboxadehyde,5-(hydroxymethyl)- 
8 9.28  C8H8O  120 0.20 Benzofuran,2,3-dihydro- 
9 11.54  C10H10O2  150 0.08 2-Methoxy,4-vinylphenol 
*10 12.73  C10H12O2  164 15.32 Phenol,2-methoxy-3-(2-propenyl)- 
11 13.39  C8H8O3  152 0.69 Vanillin 
**12 14.78  C15H24  204 1.00 Caryophyllene 
13 15.98 C15H24 204 0.27 a-Guaiene 
14 16.54  C15H24  204 0.67 Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-4a,8- 
dimethyl-2-(1-methylethenyl)-,[2R-(2α,4aa,8aa)]- 
15 17.53  C16H26O2  250 0.16 Formic acid,3,7,11-trimethyl-1,6,10-dodecatrien-3-
yl ester 
**16 18.54  C15H24O  220 1.48 Caryophyllene oxide  
**17 20.10  C15H26O  222 1.05 Epiglobulol 
18 20.97  C10H12O4  196 0.14 Benzeneacetic acid,4-hydroxy-3-methoxy-,methyl 
ester 
19 21.20  C15H24O  220 0.62 Ledene oxide-(II) 
20 21.56  C15H24O  220 0.67 Isoaromadendrene epoxide 
21 23.37  C28H48O  400 0.26 Cholestan-3-ol,2-methylene-,(3a,5a) 
**22 23.73  C20H40O  296 1.75 3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
*23 25.61  C18H30O2  278 16.94 9,12,15-Octadecatrienoic acid,(Z,Z,Z)- 
**24 26.46  C16H32O2  256 9.45 n-Hexadecanoic acid 
25 29.07  C20H40O  296 0.87 Phytol 
*26 30.06  C19H32O2  292 22.05 9,12,15-Octadecatrienoic acid,methyl ester, 
(Z,Z,Z)- 
**27 30.25  C18H36O2  284 3.59 Octadecatrienoic acid 
**28 34.43  C10H12O  148 3.16 Estragole 
29 35.51  C27H43CIO  418 0.46 4-Chlorocholest-4-en-3-one 
**30 35.74  C24H34O4  386 2.36 Pregn-5-en-20-one,3-(acetyloxy)-16,17-epoxy-6-
methyl-,(3a,16a)- 
31 36.58  C27H43CIO  418 0.72 4-Chlorocholest-4-en-3-one 
**32 42.06  C30H50  410 6.94 2,6,10,14,18,22-Tetracosahexaene 
2,6,10,15,19,23- 
hexamethyl-,(all-E)-[All trans Squalene] 
**33 42.61  C30H50  410 4.73 Squalene 
* Major constituent (≥10%); ** Minor constituent (1-10%) 
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 Table 3. Chemical constituents from mixed ethanolic Azardirachta indica and 
Ocimum sanctum leaf extract using GC-MS. 
 
 RT MF MW Peak 
(%) 
Compound 
**1 4.24 C3H8O3 92 1.38 Glycerin 
2 4.84 C6H10O2 114 0.11 2-Hexenoic acid,(E)- 
3 5.38 C9H13N 135 0.15 Benzeneethanamine,α-methyl- 
4 6.17 C5H6N2O2 126 0.60 Thymine 
5 6.61 C7H13N 111 0.51 6-Azabicyclo[3.2.1]octane 
6 7.58 C6H8O4 144 0.72 4H-Pyran-4-one,2,3-dihydro-3,5-dihydroxy-6-methyl- 
7 8.03 C15H19No7 325 0.13 Glucosamine,N-acetyl-N-benzoyl- 
**8 9.05 C6H6O3 126 1.59 2-Furancarboxadehyde,5-(hydroxymethyl)- 
*9 12.66 C10H12O2 164 20.62 Phenol,2-methoxy-3-(2-propenyl)- 
10 13.33 C8H8O3 152 0.80 Vanillin 
11 13.87 C15H24 204 0.77 Cyclohexane,1-ethyl-1-methyl-2,4-bis(1-methylenyl)-
,[1S-(1α,2β,4β)]-β-Elemen  
**12 14.75 C15H24 204 1.56 Caryophyllene 
13 16.31 C15H24 204 0.18 Eudesma-4(14),11-diene 
14 16.52 C15H24 204 0.80 Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-4a,8-
dimethyl-2-(1-methylethenyl)-,[2R-(2α,4aα,8aβ)]- 
**15 18.51 C15H24 204 2.14 γ-Elemene 
16 20.07 C15H26O 222 1.45 Globulol 
17 21.18 C15H24O 220 0.41 Ledene oxide-(III) 
18 21.53 C15H24O 220 0.81 Isoaromadendrene epoxide 
**19 23.75 C20H40O 296 2.45 3,7,11,15-Tetramethyl-2-hexadecen-1-ol 
*20 26.45 C16H32O2 256 16.58 n-Hexadecanoic acid 
**21 29.16 C20H40O  296 5.14 Phytol 
*22 30.10 C18H30O2 278 25.98 9,12,15-Octadecatrienoic acid,(Z,Z,Z) 
**23 30.30 C18H36O2 284 2.57 Octadecatrienoic acid 
**24 35.94 C24H34O4 386 3.09 Pregn-5-en-20-one,3-(acethyloxy)-16,17-epoxy-6-
methyl,(3β,16α)- 
**25 36.88 C27H43CIO 418 1.55 4-Chlorocholest-4-en-3-one 
**26 43.17 C30H50 410 7.19 Squalene 
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 Table 4. Zone of inhibition, minimum inhibitory concentration, and minimum 
bactericidal concentration of tetracycline, ethanolic decoctions, and a concoction of 













Zone of inhibition (mm) 
 Aeromonas hydrophila 25 20* 15* 23 
 Staphylococcus aureus 23 18* 12* 20 
 Streptococcus epidermidis 20 11* 9* 13* 
 Pseudomonas aeruginosa 24 13* 11* 15* 
 Vibrio harveyi 18 17 12* 19 
 Vibrio vulnificus 15 5 - 7* 
Minimum inhibition concentration (MIC) 
 Aeromonas hydrophila 5 3.68 3.82 3.20 
 Staphylococcus aureus 6 4.20 4.28 3.46 
 Streptococcus epidermidis 6 - - 4.20 
 Pseudomonas aeruginosa 8 - - 4.82 
 Vibrio harveyi 7 5.40 4.46 3.75 
 Vibrio vulnificus 6 6.74 5.80 4.46 
Minimum bactericidal concentration (MBC) 
 Aeromonas hydrophila 18 12.88 14.34 12.62 
 Staphylococcus aureus 22 18.82 18.74 14.20 
 Streptococcus epidermidis 30 - - - 
 Pseudomonas aeruginosa 26 - - 18.20 
 Vibrio harveyi 24 22.30 16.72 16.70 
 Vibrio vulnificus 34 - - - 




We identified 24 and 33 compounds from the individual ethanolic leaf extracts 
of neem and tulsi, respectively. More than 140 chemical compounds have 
been isolated from different parts of neem (Subapriya and Nagini, 2005) and 
the chemistry and structure of approximately 135 have been reviewed 
(Biswas et al., 2002). They include diterpenoids and triterpenoids containing 
protomeliacins, limonoids, azadirone and its derivatives gedunin and vilasinin, 
and non-isoprenoids such as several proteins, carbohydrates, sulphurous 
compounds, and flavonoids. In our study, four new compounds were 
identified: 6-azabicyclo[3.2.1]octane (0.51%), cyclohexane,1-ethyl-1-methyl-
2,4-bis(1-methylenyl)-,[1S-(1α,2β,4β)]-β-Elemen (0.77%), eudesma-4(14), 
11-diene (0.18%), and globulol (1.45%). These four compounds were 
analyzed by a drug-likeness activity test using online software. Drug 
effectiveness was very high in the new compounds compared to other 
constituents (data not shown). High antimicrobial activity was reported earlier 
in the same concoction extract (Harikrishnan and Balasundaram, 2005). 
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 The ethanolic leaf extracts of A. indica and A. indica+O. sanctum had 
stronger antibacterial activity against A. hydrophila than O. sanctum. 
Similarly, the MIC and MBC of the combined extract against A. hydrophila was 
lower than in extracts of either A. indica or O. sanctum. In treatments using 
the combinations Rhizoma coptidis+Radix scutellariae, Galla chinensis+Radix 
et Rhizoma rhei, G. chinensis+R. scutellariae, and R. et Rhizoma rhei+R. 
scutellariae, the MIC was significantly lower (≤4 mg/ml) than in treatments 
using R. coptidis, R. et Rhizoma rhei, or Flos lonicerae (≥32 mg/ml), alone 
(Bai et al., 2009). Although the mechanisms by which microorganisms 
generally survive the action of antimicrobial agents are poorly understood, the 
combined A. indica+O. sanctum extract may affect the cell walls of 
organisms. 
 Moderate MIC activity was noted in both decoctions and the concoction. 
The highest MIC activity was noted in A. hydrophila and S. aureus. A similar 
trend was noted in MBC activity. The bacterial strains presented MBC that 
were within two-fold dilutions of the MIC. Other reports show similar or higher 
MIC (Ramanoelina et al., 1987; Janssen et al., 1989). The highest MIC was no 
activity against S.  epidermidis and P. aeruginosa. 
 Our results agree with previous findings that natural products yield a 
variety of chemical components (Seger et al., 2004; Braga et al., 2005; 
Michielin et al., 2005). Given this, it is no surprise that 7000 pharmaceutically 
important compounds have been derived from plants and are sold to treat 
disease. The treatment of bacterial fish pathogens is problematic because 
high concentrations of antibiotics or treatment chemicals can produce 
antibiotic-resistant strains, failures, or relapses, and side effects. In contrast, 
the application of high concentrations of individual or combined herbal 
extracts produce no resistant strains or side effects. 
 The use of antibiotics, such as tetracycline, may result in residues, and 
cause the emergence of drug-resistant bacterial strains, which may be 
transferable to humans (Shao, 2001). Some antimicrobial and chemical 
agents used to treat fish diseases are increasingly ineffective. There is 
growing concern over the increase in multi-drug-resistant bacteria in human 
and veterinary medicine (Bryan, 1984). Natural products from plants and 
microorganisms contain many compounds. Researchers have been studying 
traditional folk medicines to discover the scientific basis of their remedial 
effects and seek new compounds for development of novel therapeutic agents 
(Cragg et al., 1997). 
 This is of great significance, especially in Asia where the cost of obtaining 
medical care is high and alternatives to antibiotics and chemotherapy are 
cost-effective. Our results were confirmed by in vitro antimicrobial activity 
assay, where the combined extract showed better antimicrobial activity than 
decoction extracts. Purification and characterization of the active components 
may reveal new agents important to treatment of fish diseases.  
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